Unique ID issued by UMIN | UMIN000052173 |
---|---|
Receipt number | R000059537 |
Scientific Title | Optimization of the respiration phase regarding the effects of respiratory motion on LET distribution in abdominal and pelvic carbon radiation therapy |
Date of disclosure of the study information | 2023/09/11 |
Last modified on | 2023/09/11 16:08:20 |
Optimization of the respiration phase regarding the effects of respiratory motion on LET distribution in abdominal and pelvic carbon radiation therapy
Respiratory motion in abdominal and pelvic carbon ion radiation therapy
Optimization of the respiration phase regarding the effects of respiratory motion on LET distribution in abdominal and pelvic carbon radiation therapy
Respiratory motion in abdominal and pelvic carbon ion radiation therapy
Japan |
abdominal and pelvic sarcoma
Orthopedics | Radiology |
Malignancy
NO
To investigate the relationship between respiratory phase and movement distance for abdominopelvic sarcoma and examine conditions that can ensure the robustness (stable reproducibility) of the dose distribution and LET distribution created by IMPT (intensity modulated particle therapy).
Others
Comparing the difference in the movement distance between respiratory-gated CT and 4DCT
To calculate the dose distribution and LET distribution in the phase used for irradiation and evaluate the influence of respiratory movement on DVHs and LET distributions of tumors, and organs at risk.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
NO
NO
1
Treatment
Other |
4DCT imaging
Not applicable |
Not applicable |
Male and Female
1) Patients scheduled to undergo carbon ion radiotherapy for abdominopelvic tumors within the registration period (from the date of research approval until March 31, 2025).
2) Persons who wish to participate in the research based on their own will and who are judged by the researcher's doctor to be able to understand the informed consent document.
3) If the research subject is a minor, consent can be obtained from a representative.
1) Those whose heavy ion radiotherapy was discontinued for some reason after consent was obtained.
2) Persons in whom an unexpected abnormality was found in a test conducted after consent was obtained.
3) Persons who have difficulty performing the two types of CT scans due to cognitive impairment.
4) Persons with metal implants that affect treatment planning CT.
5) Other persons who are judged to be ineligible as research subjects by a doctor who is a researcher, etc.
20
1st name | Reiko |
Middle name | |
Last name | Imai |
National Institute of Quantum Science and Technology
QST Hospital
2630024
4-9-1 Anagawa Inage Chiba
0432063306
imai.reiko@qst.go.jp
1st name | Reiko |
Middle name | |
Last name | Imai |
National Institute of Quantum Science and Technology
QST Hospital
2630024
4-9-1 Anagawa, Inage, Chiba
0432063306
imai.reiko@qst.go.jp
National Institute of Quantum Science and Technology
National Institute of Quantum Science and Technology
Other
National Institutes for Quantum Science and Technology
4-9-1 Anagawa, Inage, Chiba
0432063306
imai.reiko@qst.go.jp
NO
2023 | Year | 09 | Month | 11 | Day |
Unpublished
Open public recruiting
2023 | Year | 08 | Month | 16 | Day |
2023 | Year | 08 | Month | 30 | Day |
2023 | Year | 09 | Month | 11 | Day |
2025 | Year | 12 | Month | 31 | Day |
2023 | Year | 09 | Month | 11 | Day |
2023 | Year | 09 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059537